Covered recipient · General Payments record
ALINA GOULLER
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$4,750.11
- Reported across 91 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $777.00 | 1 |
| Food and Beverage | $330.11 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ROCHE DIABETES CARE, INC. | $777.00 | 1 |
| Novo Nordisk AS | $183.92 | 6 |
| BETA BIONICS, INC. | $42.71 | 2 |
| Antares Pharma, Inc. | $33.99 | 2 |
| CeQur Corporation | $30.28 | 1 |
| Lilly USA, LLC | $20.56 | 1 |
| MannKind Corporation | $18.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Antares Pharma, Inc. | $14.76 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146460935 | CMS |
| Antares Pharma, Inc. | $19.23 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146460939 | CMS |
| BETA BIONICS, INC. | $24.41 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087888823 | CMS |
| BETA BIONICS, INC. | $18.30 | 12/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087889991 | CMS |
| CeQur Corporation | $30.28 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126846448 | CMS |
| Lilly USA, LLC | $20.56 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136023606 | CMS |
| Mannkind Corporation | $18.65 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145842578 | CMS |
| Novo Nordisk Inc | $7.27 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096585519 | CMS |
| Novo Nordisk Inc | $124.39 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097765496 | CMS |
| Novo Nordisk Inc | $20.73 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096642342 | CMS |
| Novo Nordisk Inc | $2.95 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096920900 | CMS |
| Novo Nordisk Inc | $2.39 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130818258 | CMS |
| Novo Nordisk Inc | $26.19 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130818262 | CMS |
| ROCHE DIABETES CARE, INC. | $777.00 | 02/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125820530 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.